Awards & Recognition

servier in the u.s.

At Servier, our commitment to excellence has not gone unnoticed.

We are proud recipients of multiple awards across scientific, patient and cultural categories – a testament to our unwavering dedication to innovation and quality. These accolades inspire us to continue pushing boundaries and delivering exceptional solutions for the benefit of the patients we serve.

PR Daily recognizes impressive media relations work done both in-house and by agencies across industries. Servier was recognized as a finalist in the Research Communications category in 2023.

The Fierce Innovation Awards look to uncover cutting edge organizations that have or are in the process of launching new technologies, services or treatments that are reinventing what it means to be focused on helping people.
Servier was named a finalist in the Biotech Innovation category in 2023.

The Citeline Awards look to honor the greatest innovation in clinical R&D each year. Servier was named a finalist in the Clinical Research Team of the Year category in 2023.

Each year the PharmaVoice 100 recognizes inspiring leaders in the life sciences space. In 2023, David K. Lee, CEO of Servier Pharmaceuticals, was recognized as a Cancer Care Visionary.

No alternative text description for this image

Boston Biotech Week recognizes a standout life-sciences organization or person based in the Boston area that has made a significant contribution to the biopharmaceutical industry over the past year.

Servier was recognized as a finalist in the Boston Highlight Category in 2023.

The Reuter’s Patient Champion Award recognizes a company that acts as an advocate and amplifies the voice of the patient community. This may include supporting new patient community growth or movement, policy change, awareness raising, increased health literacy and education, and launching of a product.

Servier was recognized as a winner of this award in 2022.

Boston Biotech Week recognizes recognizes an organization or group that has advanced diversity, equity, and inclusion in the workplace by championing the perspectives and contributions of employees representing marginalized groups.

Servier received the DE&I Champion award in 2022.

The Boston Business Journal’s Best Places to Work is designed to honor the area’s leading employers – looking for companies that go beyond the norm to foster an enjoyable and meaningful work environment for their employees.

Servier was named a best place to work in 2021, 2022 and 2023.

Pharmaceutical Executive’s Emerging Pharma Leaders awards recognition program was established to recognize select industry executives whose peers and supervisors believe will change the future of the pharma industry.

David K. Lee was recognized among this esteemed group in 2020 and Susan Pandya was recognized in 2022.

The PatientView Annual Report: Corporate Reputation of Pharma 2021 ranks leading pharmaceutical companies on various measures, including transparency, patient-centricity, integrity and supporting patients during the pandemic.

Servier ranked 3rd overall in the 2022 report.

The LifeSci Voice Top Industry Leader Award recognizes those who are driving the industry forward through remarkable contributions and transformational work, playing a critical role in advancing science and organizational excellence to ensure uninterrupted service to those in need.

David K. Lee was recognized among these esteemed leaders in 2021.

The Reuters Events Global Pharma Awards showcases pharma leaders, pioneers, innovators who are creating real value for customers and patients.

Servier was named as a finalist for the Patient Champion Pharma Award for the Patient Expert Council in 2021. The finalist video can be found here.

The Scrip Awards applaud the essential role that the pharmaceutical and biotech industries play in improving healthcare.

David K. Lee was a finalist for Executive of the Year in 2020 and 2021, while Servier’s Business Development Team was recognized as a finalist in 2021. Servier’s Phase III INDIGO study of vorasidenib was also recognized as a finalist for Clinical Advance of the Year in 2023.

The Prix Galien USA Awards aim to promote significant advances in pharmaceutical research and recognize excellence in biopharmaceutical and medical technology innovations that improve the human condition.

Servier was recognized as a finalist for Best Pharmaceutical Agent in 2020 and 2021, the team was also recognized as a finalist for Best Pharmaceutical Product in 2023.

The Massachusetts Economic Impact Award honors employers that have grown in Massachusetts with facility expansions, financial investments, increased employment, and community engagement Servier received the Bronze award (for Greater Boston Area) in 2019.